Adenosine A2a Receptor antibody (Center)
Quick Overview for Adenosine A2a Receptor antibody (Center) (ABIN654424)
Target
See all Adenosine A2a Receptor (ADORA2A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 273-301, Center
-
Specificity
- This ADORA2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 280-309 amino acids from the Central region of human ADORA2A.
-
Predicted Reactivity
- Mouse (Murine),Rat (Rattus)
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This ADORA2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 273-301 AA from the Central region of human ADORA2A.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB = 1:1000, IF = 1:10-50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Expiry Date
- 6 months
-
-
- Adenosine A2a Receptor (ADORA2A)
-
Alternative Name
- ADORA2A
-
Background
-
ADORA2A is a protein which is one of several receptor subtypes for adenosine. The activity of the encoded protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. This protein is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine.
Synonyms: ADORA2A,Adenosine receptor A2a,ADORA2 -
Molecular Weight
- 44707 DA
-
Gene ID
- 135
-
NCBI Accession
- NP_000666
-
UniProt
- P29274
-
Pathways
- Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Target
-